Name (Synonyms) | Correlation | |
---|---|---|
drug299 | BMS-986256 Wiki | 1.00 |
drug1492 | Milk of magnesia Wiki | 1.00 |
drug341 | Best supportive care" which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.11 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Randomized, Parallel Group, Active Controlled Trial
Description: 1-month mortality is defined as the ratio of patients who will live after 1 month from study start out of those registered at baseline
Measure: One-month mortality rate between the two arms Time: One-monthDescription: Baseline, during treatment, One month
Measure: Biomarkers (IL-6, TNF-a, IL1, IL17, etc…) Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: Lymphocyte count Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: CRP (C-reactive protein) level Time: One MonthDescription: Baseline, during treatment (Before every dose and 12 h post dose) up to 1 month
Measure: PaO2 (partial pressure of oxygen) / FiO2 (fraction of inspired oxygen, FiO2) ratio (or P/F ratio) Time: One MonthDescription: At baseline, after seven days and if clinically indicated (up to 1 month)
Measure: Radiological response Time: one monthDescription: from baseline up to patients discharge (up to 1 month)
Measure: Duration of hospitalization Time: One MonthDescription: up to 1 month
Measure: Remission of respiratory symptoms Time: One Month